Regeneron Pharmaceuticals (REGN) Long-Term Debt Issuances (2009 - 2011)

Regeneron Pharmaceuticals (REGN) posted quarterly Long-Term Debt Issuances of $391.1 million for Q4 2011, up 722.62% quarter-over-quarter from $47.5 million in Q1 2010.

Regeneron Pharmaceuticals (REGN) Long-Term Debt Issuances (2009 - 2011) Analysis & Trends

Regeneron Pharmaceuticals' Long-Term Debt Issuances history runs 3 years deep, the most recent figure standing at $391.1 million for Q4 2011.

  • In Q4 2011, Long-Term Debt Issuances changed N/A year-over-year to $391.1 million; the TTM figure through Dec 2021 stood at $391.1 million (changed 0.0% YoY), while the FY2020 annual figure was $2.0 billion, changed N/A from the prior year.
  • Long-Term Debt Issuances for Q4 2011 stood at $391.1 million, up from $47.5 million in the prior quarter.
  • The five-year high for Long-Term Debt Issuances was $391.1 million in Q4 2011, with the low at $18.5 million in Q4 2009.
  • The 3-year median for Long-Term Debt Issuances is $47.5 million (2010), against an average of $152.4 million.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -675,522.58
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -
10 Roivant Sciences 26.16 Bn 26.85 Bn 1.16 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2011 391.11 Mn
Dec 31, 2011 391.11 Mn
Mar 31, 2010 47.54 Mn
Mar 31, 2010 47.54 Mn
Dec 31, 2009 18.46 Mn
Dec 31, 2009 18.46 Mn